Skip to content

Excellos vs ImmunoACT

Excellos logo

Excellos

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

38 employees · est. 2021 · San Diego, United States

VS
ImmunoACT logo

ImmunoACT

India's Leader in Cell & Gene Therapies

99 employees · est. 2018 · Navi Mumbai, India

ImmunoACT is the older company (2021 vs 2018); ImmunoACT is the larger of the two.

Side-by-Side Comparison

Excellos ImmunoACT
Founded
2021 2018 older
Headquarters
San Diego, United States Navi Mumbai, India
Employees
38 99 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology
Funding Stage
Corporate Round Corporate Round
Total Funding
$20.00M $1.40B
Funding Rounds
3 3
Taxonomy
Cell And Gene TherapyCDMOCGMP ManufacturingTIL TherapiesCAR-T TherapyImmunotherapy +8 Cell TherapyGene TherapyIIT-BombayStartupTranslational ResearchViral Vector Process Development +5
Website
excellos.com ImmunoACT.com
Excellos logo

About Excellos

Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new in...

ImmunoACT logo

About ImmunoACT

ImmunoACT is a pioneering biotechnology startup, proudly based in India, that specializes in the development of indigenous Cell & Gene Therapy. Founded in 2018 as a spin-out from IIT-Bombay, the company has quickly established itself as a leader in the field, with a strong focus on addressing unmet...

Also comparing in this category

Comparing more than these two?

Get Excellos, ImmunoACT and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Excellos compare?

A PDF of Excellos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Excellos was founded in 2021, based in San Diego, United States, with 38 employees. Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and r. ImmunoACT was founded in 2018, based in Navi Mumbai, India, with 99 employees. ImmunoACT is a pioneering biotechnology startup, proudly based in India, that specializes in the development of indigenous Cell & Gene Therapy. Founded in 2018 as a spin-out from IIT-Bombay, the compa.
Excellos has raised $20.00M and ImmunoACT $1.40B. Latest stage: Excellos Corporate Round, ImmunoACT Corporate Round.
Both work in Biotechnology.

Compare Excellos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Excellos on 11 Sep 2024, and ImmunoACT on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout